These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 21827485)

  • 1. Determination of trace amounts of β tegafur in commercial α tegafur by powder X-ray diffractometric analysis.
    Petkune S; Bobrovs R; Actiņš A
    J Pharm Pharmacol; 2011 Sep; 63(9):1136-40. PubMed ID: 21827485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of sample preparation conditions for detecting trace amounts of β-tegafur in α- and β-tegafur mixture.
    Bobrovs R; Actiņš A
    J Pharm Sci; 2012 Dec; 101(12):4608-14. PubMed ID: 22997010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organic solvent vapor effects on phase transition of α and β tegafur upon grinding with solvent additives.
    Bobrovs R; Saveļjeva O; Kapace A; Plauka Z; Actiņš A
    Int J Pharm; 2013 Feb; 443(1-2):193-8. PubMed ID: 23318369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organic solvents vapor pressure and relative humidity effects on the phase transition rate of α and β forms of tegafur.
    Petkune S; Bobrovs R; Actiņš A
    Pharm Dev Technol; 2012; 17(5):625-31. PubMed ID: 21639726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of crystalline forms in active pharmaceutical ingredient and tablets by X-ray powder diffraction.
    Cooper VB; Pearce GE; Petts CR
    J Pharm Pharmacol; 2003 Sep; 55(9):1323-9. PubMed ID: 14604477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative determination of famotidine polymorphs: X-ray powder diffractometric and Raman spectrometric study.
    Német Z; Kis GC; Pokol G; Demeter A
    J Pharm Biomed Anal; 2009 Feb; 49(2):338-46. PubMed ID: 19131203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastability and transformation of polymorphic crystals in biodegradable poly(butylene adipate).
    Gan Z; Kuwabara K; Abe H; Iwata T; Doi Y
    Biomacromolecules; 2004; 5(2):371-8. PubMed ID: 15002996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of sample preparation method on quantification of polymorphs using PXRD.
    Alam S; Patel S; Bansal AK
    Pharm Dev Technol; 2010; 15(5):452-9. PubMed ID: 19842910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative determination of polymorphic composition in intact compacts by parallel-beam X-ray powder diffractometry II. Data correction for analysis of phase transformations as a function of pressure.
    Wildfong PL; Morley NA; Moore MD; Morris KR
    J Pharm Biomed Anal; 2005 Sep; 39(1-2):1-7. PubMed ID: 15869857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A computationally inspired investigation of the solid forms of (R)-1-phenylethylammonium-(S)-2-phenylbutyrate.
    Antoniadis CD; D'Oria E; Karamertzanis PG; Tocher DA; Florence AJ; Price SL; Jones AG
    Chirality; 2010 May; 22(4):447-55. PubMed ID: 19644934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solubility measurement of polymorphic compounds via the pH-metric titration technique.
    Fioritto AF; Bhattachar SN; Wesley JA
    Int J Pharm; 2007 Feb; 330(1-2):105-13. PubMed ID: 17049191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative determination of polymorphic impurity by X-ray powder diffractometry in an OROS formulation.
    Varasteh M; Deng Z; Hwang H; Kim YJ; Wong GB
    Int J Pharm; 2009 Jan; 366(1-2):74-81. PubMed ID: 18840515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of polymorphic impurity in an enantiotropic polymorph system using differential scanning calorimetry, X-ray powder diffraction and Raman spectroscopy.
    Li Y; Chow PS; Tan RB
    Int J Pharm; 2011 Aug; 415(1-2):110-8. PubMed ID: 21645601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Organic solvent desorption from two tegafur polymorphs.
    Bobrovs R; Actiņš A
    Int J Pharm; 2013 Nov; 457(1):110-7. PubMed ID: 24060368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative solid-state analysis of three solid forms of ranitidine hydrochloride in ternary mixtures using Raman spectroscopy and X-ray powder diffraction.
    Chieng N; Rehder S; Saville D; Rades T; Aaltonen J
    J Pharm Biomed Anal; 2009 Jan; 49(1):18-25. PubMed ID: 19081220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thermal and X-ray powder diffraction structural characterization of two benfluorex hydrochloride polymorphs.
    Maccaroni E; Malpezzi L; Panzeri W; Masciocchi N
    J Pharm Biomed Anal; 2010 Sep; 53(1):1-6. PubMed ID: 20347245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Crystalline polymorphism of eflucimibe].
    Ribet JP; Pena R; Chauvet A; Patoiseau JF; Autin JM; Segonds R; Basquin M; Autret JM
    Ann Pharm Fr; 2002 May; 60(3):177-86. PubMed ID: 12050596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphism of potassium ferrocyanide trihydrate as studied by solid-state multinuclear NMR spectroscopy and X-ray diffraction.
    Willans MJ; Wasylishen RE; McDonald R
    Inorg Chem; 2009 May; 48(10):4342-53. PubMed ID: 19425611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural characteristics and crystal polymorphism of three local anaesthetic bases crystal polymorphism of local anaesthetic drugs: part VII.
    Schmidt AC
    Int J Pharm; 2005 Jul; 298(1):186-97. PubMed ID: 15955643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphism of linezolid: a combined single-crystal, powder diffraction and NMR study.
    Maccaroni E; Alberti E; Malpezzi L; Masciocchi N; Vladiskovic C
    Int J Pharm; 2008 Mar; 351(1-2):144-51. PubMed ID: 17977677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.